Trial Profile
Clinical study of combined use of apaitinib in patients with locally advanced cervical cancer during concurrent radiotherapy and chemotherapy
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 21 Feb 2017
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary) ; Cisplatin
- Indications Cervical cancer
- Focus Therapeutic Use
- 21 Feb 2017 New trial record